Views & Analysis The patient voice: A call to action On December 13th 2016 the 21st Century Cures Act (Cures Act) was signed into law in the US.
Views & Analysis FDA’s Califf embraces 21st Century Cures – but questions rem... Yesterday the outgoing President of the United States Barack Obama signed into law the 21st Century Cures Act, which has been called the most momentous health legislation in the country since t
Views & Analysis Digital health round-up – Fitbit’s smartwatch acquisition A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News BioNTech to buy rival mRNA firm CureVac for $1.25bn BioNTech has agreed to buy another specialist in mRNA medicines, fellow German biotech CureVac, for around $1.25 billion.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
